International audienceHumans have invested several genes in DNA repair and fidelity replication. To account for the disparity between the rarity of mutations in normal cells and the large number of mutations present in cancer, an hypothesis is that cancer cells must exhibit a mutator phenotype (genomic instability) during tumor progression, with the initiation of abnormal mutation rates caused by the loss of mismatch repair. In this study we introduce a stochastic model of mutation in tumor cells with the aim of estimating the amount of genomic instability due to the alteration of DNA repair genes. Our approach took into account the difficulties generated by sampling within tumoral clones and the fact that these clones must be difficult to ...
Identifying driver mutations in cancer is notoriously difficult. To date, recurrence of a mutation i...
Identifying driver mutations in cancer is notoriously difficult. To date, recurrence of a mutation i...
Genomic instability is a major driver of intra-tumor heterogeneity. However, unstable genomes often ...
Tumors often harbor orders of magnitude more mutations than healthy tissues. The increased number of...
<div><p>Mutator phenotypes accelerate the evolutionary process of neoplastic transformation. Histori...
One of the hallmarks of cancer is the extremely high mutability and genetic instability of tumor cel...
The emergence of a predominant phenotype within a cell population is often triggered by the chance a...
Human cancer somatic mutations arise from a variety of biological processes. Different processes pro...
Cancer research needs to explain the observed incidence of cancer. Many factors determine this proce...
A) Number of mutations (left panel) and number of clones (right panel) in tumor types and subtypes w...
Mutator phenotypes accelerate the evolutionary process of neoplastic transformation. His-torically, ...
Tumorigenesis requires multiple genetic changes. Mutator mutations are mutations that increase genom...
Abstract Background Because driver mutations provide ...
Many processes can cause the same nucleotide change in a genome, making the identification of the m...
Cancer initiation, progression, and the emergence of drug resistance are driven by specific genetic ...
Identifying driver mutations in cancer is notoriously difficult. To date, recurrence of a mutation i...
Identifying driver mutations in cancer is notoriously difficult. To date, recurrence of a mutation i...
Genomic instability is a major driver of intra-tumor heterogeneity. However, unstable genomes often ...
Tumors often harbor orders of magnitude more mutations than healthy tissues. The increased number of...
<div><p>Mutator phenotypes accelerate the evolutionary process of neoplastic transformation. Histori...
One of the hallmarks of cancer is the extremely high mutability and genetic instability of tumor cel...
The emergence of a predominant phenotype within a cell population is often triggered by the chance a...
Human cancer somatic mutations arise from a variety of biological processes. Different processes pro...
Cancer research needs to explain the observed incidence of cancer. Many factors determine this proce...
A) Number of mutations (left panel) and number of clones (right panel) in tumor types and subtypes w...
Mutator phenotypes accelerate the evolutionary process of neoplastic transformation. His-torically, ...
Tumorigenesis requires multiple genetic changes. Mutator mutations are mutations that increase genom...
Abstract Background Because driver mutations provide ...
Many processes can cause the same nucleotide change in a genome, making the identification of the m...
Cancer initiation, progression, and the emergence of drug resistance are driven by specific genetic ...
Identifying driver mutations in cancer is notoriously difficult. To date, recurrence of a mutation i...
Identifying driver mutations in cancer is notoriously difficult. To date, recurrence of a mutation i...
Genomic instability is a major driver of intra-tumor heterogeneity. However, unstable genomes often ...